Stamos Capital Partners, L.P. Illumina, Inc. Transaction History

Stamos Capital Partners, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $1.71 Million - $2.55 Million	13,260 New	13,260 $1.82 Million
Q3 2022 Nov 10, 2022	BUY	$177.23 - $227.44 $239,260 - $307,044	1,350 Added 103.85%	2,650 $506,000
Q1 2022 May 13, 2022	BUY	$303.87 - $423.8 $395,031 - $550,940	1,300 New	1,300 $454,000
Q4 2019 Feb 14, 2020	SELL	$288.29 - $335.49 $222,559 - $258,998	-772 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $158,502 - $224,668	-594 Reduced 43.48%	772 $235,000
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $345,678 - $423,372	-1,150 Reduced 45.71%	1,366 $506,000
Q1 2019 May 10, 2019	SELL	$272.57 - $321.18 $272,570 - $321,180	-1,000 Reduced 28.44%	2,516 $808,000
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $957,969 - $1.29 Million	3,516 New	3,516 $1.06 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Stamos Capital Partners, L.P. with notifications on news.